We are live on
!
Find out more
RG
Redmile Group Portfolio holdings
AUM
$1.51B
1-Year Est. Return
164.17%
This Fund
S&P 500
This Quarter
Est. Return
-3.89%
1 Year Est. Return
+164.17%
3 Year Est. Return
+929.47%
5 Year Est. Return
+823.75%
10 Year Est. Return
+18,826.17%
AUM
$2.3B
AUM Growth
-$140M
(-5.7%)
Cap. Flow
+$106M
Cap. Flow
% of AUM
4.61%
Top 10 Holdings %
Top 10 Hldgs %
42.59%
Holding
80
New
11
Increased
12
Reduced
36
Closed
4
Top Buys
| 1 |
CTLT
CATALENT, INC.
CTLT
|
+$37.7M |
| 2 |
DexCom
DXCM
|
+$37.6M |
| 3 |
BioMarin Pharmaceuticals
BMRN
|
+$34.7M |
| 4 |
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
|
+$33.2M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$31.7M |
Top Sells
| 1 |
ONEM
1Life Healthcare
ONEM
|
+$38.9M |
| 2 |
Xenon Pharmaceuticals
XENE
|
+$38.2M |
| 3 |
Pliant Therapeutics
PLRX
|
+$27.1M |
| 4 |
AKRO
Akero Therapeutics
AKRO
|
+$26.2M |
| 5 |
Replimune Group
REPL
|
+$24.2M |
Sector Composition
| 1 | Healthcare | 98.78% |
| 2 | Industrials | 1.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RAPT
51
DELISTED
RAPT Therapeutics
RAPT
| $12.6M | 0.55% |
86,017
-12,087
| -12% | -$2.44M |
|
|
ALLK
52
DELISTED
Allakos
ALLK
| $10.2M | 0.44% |
2,286,177
-259,098
| -10% | -$1.66M |
|
|
MDVL
53
DELISTED
MedAvail Holdings, Inc. Common Stock
MDVL
| $9.92M | 0.43% |
692,090
| – | – |
|
54
Boston Scientific
BSX
$64.2B
| $8.59M | 0.37% |
+171,780
| New | +$8.1M |
|
55
Illumina
ILMN
$28.4B
| $7.79M | 0.34% |
+34,434
| New | +$7.05M |
|
|
KLRS
56
Kalaris Therapeutics
KLRS
$110M
| $7.52M | 0.33% |
82,955
| – | – |
|
|
SNCE
57
DELISTED
Science 37 Holdings, Inc. Common Stock
SNCE
| $5.58M | 0.24% |
990,412
| – | – |
|
|
GRFS
58
Grifois
GRFS
$4.87B
| $5.31M | 0.23% |
720,784
+395,184
| +121% | +$3.43M |
|
59
Nuvation Bio
NUVB
$2.03B
| $5.03M | 0.22% |
3,031,009
| – | – |
|
|
SLGC
60
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
| $4.77M | 0.21% |
1,870,839
+370,839
| +25% | +$1.06M |
|
|
LVTX
61
DELISTED
LAVA Therapeutics
LVTX
| $3.44M | 0.15% |
2,074,372
-741,824
| -26% | -$2.08M |
|
|
NVTA
62
DELISTED
Invitae Corporation
NVTA
| $3.08M | 0.13% |
2,280,403
| – | – |
|
63
Stereotaxis
STXS
$160M
| $3.03M | 0.13% |
1,487,495
| – | – |
|
64
ALX Oncology
ALXO
$272M
| $2.65M | 0.12% |
586,977
-20,493
| -3% | -$155K |
|
65
Cabaletta Bio
CABA
$445M
| $2.27M | 0.1% |
274,252
-190,000
| -41% | -$1.78M |
|
|
HOOK
66
DELISTED
HOOKIPA Pharma
HOOK
| $1.88M | 0.08% |
255,295
-56,182
| -18% | -$503K |
|
67
Invivyd
IVVD
$234M
| $1.73M | 0.08% |
1,440,725
| – | – |
|
68
Xeris Biopharma Holdings
XERS
$1.47B
| $1.71M | 0.07% |
1,046,587
| – | – |
|
|
ACHL
69
DELISTED
Achilles Therapeutics
ACHL
| $1.54M | 0.07% |
1,608,089
| – | – |
|
70
Neurogene
NGNE
$787M
| $1.29M | 0.06% |
92,380
-148
| -0.2% | -$1.74K |
|
71
Alpha Teknova
TKNO
$283M
| $1.1M | 0.05% |
373,244
-184,855
| -33% | -$924K |
|
|
SONX
72
DELISTED
Sonendo, Inc.
SONX
| $996K | 0.04% |
498,131
| – | – |
|
|
TCRR
73
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $988K | 0.04% |
658,336
-73,043
| -10% | -$98.4K |
|
74
Cytosorbents Corp
CTSO
$25.1M
| $612K | 0.03% |
181,639
-84,726
| -32% | -$254K |
|
|
BCEL
75
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
| $505K | 0.02% |
442,653
| – | – |
|
Similar funds
ORI
GAI
HCMG
FMI
FCM
PP
AM
BFO